New Britain woman admits to stealing more than $200K in CARES Act, PPP loan funds

A 35-year-old New Britain woman was sentenced to three months in prison and two years of supervised release after pleading ...
FOX61

Connecticut woman sentenced for fraudulently stealing $217K in COVID funds

Victoria Kates, 35, of New Britain was sentenced to three months in prison in Hartford federal court Friday for fraudulently ...

A CT woman owes the government $233K. Her complicated scheme drew in family and friends.

Kates in April pleaded guilty to two counts of wire fraud; Nagala ordered her to pay $233,306 in restitution. Kates is free ...
The Manila Times

MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss ...
The Print

Grounded no more: Andhra govt revives no-frills Dagadarthi airport near Nellore to boost south coast link

While Visakhapatnam readies for a mega airport, the Chandrababu Naidu govt has brought back its low-cost, greenfield project ...
Guyana Chronicle

Empowered Female Farmer at the Frontline of Food Security

NEATLY tucked away along a quiet street in Den Amstel Village, West Coast Demerara, is the well-kept home and farm of Abiola “Goldie” Hill. Surrounded by ...

BLA for subcutaneous formulation of Leqembi® accepted in China

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for ...

MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day

MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Applic ...
Việt Báo

The Politburo issued a Resolution on the development of the state-owned economy.

The resolution sets a target of having 50 state-owned enterprises (SOEs) in the top 500 in Southeast Asia by 2030, and 1-3 ...

BioArctic: BLA for subcutaneous formulation of Leqembi accepted in China

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation ...
Santé log

Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Accepted in China

Eisai serves as the lead of LEQEMBI development and regulatory submissions globally with Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making ...